kg49bAWQQD

Capital

More from Vishnu Kapadia

Thread on Astec Lifesciences Ltd 🧵

Market cap: 1996.7 crores.
Revenues: 522.61 crores.
P/E: 27.62
P/B: 7.0
ROCE: 20.44%
ROE: 21.24%

Here we go👇

ASTEL is a niche chemical company focused on triazole fungicides & on proprietary off-patent products in the CRAMS segment;

1/25

New products in the herbicides segment should drive growth in the CRAMS space.

Leader in triazole fungicides:

Tebuconazole and Propiconazole currently form a major part of ASTEL’s enterprise business while it is capable of venturing into newer products given strong

2/25

technical knowledge in triazole chemistry.

Newer mixtures/geographies to drive growth in Enterprise business:

Triazole fungicides have been losing market share over the years as new products (SDHI fungicides) have proved to be a replacement;

3/25

However, with a few SDHI (succinate dehydrogenase inhibitors) products facing resistance in some geographies and given strong forecasts for this segment, triazole fungicides are likely to benefit–albeit in a limited way–from their inclusion in a

4/25

mixture of products (with some SDHIs).

ASTEL is setting up a new herbicide plant To diversify its product concentration from the triazole fungicide segment.

New R&D Centre to aid diversification:

Would help develop new processes into various chemistries like fluorine;

5/25

Vishnu Kapadia
@MJKinvestments

As part of our comparative analysis series, this month we covered two Engineering R&D companies.

Link to our presentation on, Tata Elxsi versus LTTS.

https://t.co/nsRLGpbt6L

Presentation only for educational purpose and should not be seen as an investment recommendation.

Vishnu Kapadia
@MJKinvestments

Thread on Glenmark Life Science IPO 27 July 🧵:

Glenmark Life Science (GLS) is the wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd;

In 2001-02, GLS launched the API manufacturing business; Currently, the company has two key business verticals: namely API and CDMO;

1/25

GLS is a leading developer and manufacturer of select high-value, non-commoditized APIs in chronic therapeutic areas, including CVS, CNS, pain, and diabetes;

As of FY21, API and CDMO contributed ~90.6 & 8.1% to GLS revenues respectively;

2/25

The company works with 16 of the top 20 generic pharma companies in the world and as of 31st May 2021, they have registered ~403 DMFs globally;

From the IPO proceeds, GLS will be using ~Rs 8bn as repayment of an outstanding purchase agreement to the promoter-

3/25

-for the spin-off of the API business. The company has also envisaged using Rs 1.53bn as capital expenditure;

This includes a new multi-usage facility, which will mainly focus on the company’s CDMO business aspiration from 4QFY23.

4/25

Key growth drivers for the Indian API industry:

👉India is on par with other countries in terms of technological capabilities and process efficiency;

👉The costs are very low in India: Domestic pharmaceutical facilities cost only 2/5th of what it costs to set up and-

5/25

Vishnu Kapadia
@MJKinvestments

Thread on IDFC first Bank 🧵

Market cap: 37,087 crores
Revenues: 15,968 crores
P/E: 82
P/B: 2.42
ROE: 2.95%

Here we go 👇

1/25

Unique evolution,

On getting a license, it was created out of a demerger of infrastructure financing business followed by the merger of erstwhile Capital First;

Stress build-up and franchise investment resulted in a weak Return profile during the transition phase;

2/25

After merger of Capital First, with Mr. V. Vaidyanathan at the helm, management is focused on building a high-yielding retail banking franchise (average retail yield at >15%);

Infrastructure loans to be completely run down, selective lending in non-infra corporate segment:

3/25

Of the wholesale exposure, infra book has been almost halved since merger to Rs108bn and will be further rationalized to a very negligible proportion in 3-5 years;

4/25

Remarkable transition in asset and liability profile post the merger:

After having rolled out a 5-year strategic roadmap towards targeted RoA and RoE of 1.4-1.6% and 13-15% respectively, it has made significant strides on most operating parameters:-

5/25

Vishnu Kapadia
@MJKinvestments

Deepak Nitrite Client Base,
(Source 50th Annual Report 2020-2021)

More from Bookstoread

$The_Chartist \U0001f4c8$

The_Chartist 📈...
@nison_steve

@SAnngeri Many books - Edwards & Magee, John Murphy, Richard Schabacker, Richard Wyckoff and etc.. then practice along with it. Practice and cash trading with small money is the best teacher

Mark Minervini
@markminervini

https://t.co/uag3BwHMkj

Nooresh Merani
@nooreshtech

#LearnTechnicalAnalysis

Learning Technical Analysis

Free E-Book https://t.co/j1ImYefBv1

How to Trade Smallcaps and Midcaps using Technical Analysis.https://t.co/XG8iAKJpgz

Online Training Program.

About the coursehttps://t.co/StCRSyg7bK

Subscription Link
— Nooresh Merani (@nooreshtech) December 18, 2020

Abhishek Kar
@Abhishekkar_

Books on trading which every SERIOUS TRADER should read
⚡Trading in the Zone : Mark Douglas
⚡Market Wizards : Jack D.S.
⚡Technical Analysis : J.Murphy
⚡How to make money using charts : Ashwini Gujral
⚡Japanese Candlesticks : Steve Nison
⚡ Reminiscence of a stock operator

Himanshu Chauhan
@pahari_trader

A thread on Top 10 books every
trader/investor must read 📚

(Would appreciate Retweet, it helps to educate more people and inspire us to work more)
⬇️

1)
⚡The intelligent investor
By Benjamin Graham

2)
⚡Trading in the zone
By Mark Douglas

3)
⚡Rich Dad Poor Dad
By Robert Kiyosaki

4)
⚡The Disciplined Trader
By Mark Douglas

FEW USEFUL CHARTINK SCANNERS :

This Scanner will be More than Enough for any Swing / Positional Trader to find Good Stocks.

Few Important Chart ink Scanners which can help you to find Setups and boost up your Trading Account : 🧵

Do Retweet If you If it Useful

1. Momentum Stocks

This Scanner can be helpful for Short term Swing Trades . you can easily find Stocks which are in Momentum.

Stocks which are up by 20 % in 5 Days
Stocks which are up by 30 % in 30 Days
Stocks which are up by 30 % in 30 Days

2. Volume Spike

We always Look for Price and Volume Confirmation for Breakout Trading. This scanner will help you to find the Stocks Which has given a move with Good Volume . You can keep this Stock in Radar and catch the Next move in them :

3 . Reversal Scan

Stocks which are Down by 20 % + in 5 days

When Market Corrects for sometime , You can find Stocks where selling is Exhausted and they can make a Good Reversal move .

4. Reversal Scan - Stock Down continues 5 days .

If you Know the Concept of 3-5 Days move . you might catch few stocks from this scanner. Always try and Pick stocks which are in strong momentum , you have more Chances of Getting Right in Reversal Trade.

Noah Smith
@Noahpinion

Krugman is, of course, right about this. BUT, note that universities can do a lot to revitalize declining and rural regions.

One thing I've been noticing about responses to today's column is that many people still don't get how strong the forces behind regional divergence are, and how hard to reverse 1/ https://t.co/Ft2aH1NcQt
— Paul Krugman (@paulkrugman) November 20, 2018

See this thing that @lymanstoneky wrote:

And see this thing that I wrote:

And see this book that @JamesFallows wrote:

And see this other thing that I wrote: